Simultaneous staining of sputum smears for acid-fast and lipid-containing Myobacterium tuberculosis can enhance the clinical evaluation of antituberculosis treatments

Tuberculosis
Xavier A KayigireAndreas H Diacon

Abstract

Dormant, slow-growing, antibiotic-tolerant Mycobacterium tuberculosis undermine the shortening of tuberculosis treatment to less than 6 months and are thought to be characterised by intracellular lipid bodies. Antibiotic effects on such persisting bacilli escape evaluation as they cannot be readily cultured. We identified cells containing lipid bodies in sputum smears from 86 newly diagnosed pulmonary tuberculosis patients and monitored these cells daily in 42 patients over the first 14 days of treatment with rifampicin, the experimental compound SQ-109, or both agents combined. Counts of Nile-Red-positive lipid-body containing cells were correlated with those of Auramine-O-positive cells and colony forming units of viable Mycobacterium tuberculosis on agar plates. Rifampicin but not SQ-109 significantly reduced colony forming units but all treatments distinctively and significantly changed the proportions of lipid body-containing bacilli and viable Mycobacterium tuberculosis. Monitoring lipid-body containing bacilli in sputum during treatment with experimental antituberculosis regimens may identify putative treatment-shortening regimens.

References

Apr 1, 1993·The American Review of Respiratory Disease·D A Mitchison
Sep 7, 2001·Annual Review of Microbiology·L G Wayne, C D Sohaskey
Oct 9, 2002·Microbiology·Natalie J GartonMichael R Barer
Nov 1, 2003·The Journal of Infectious Diseases·Peter SeilerPeter Aichele
Dec 13, 2003·Tuberculosis·James E Gomez, John D McKinney
Mar 29, 2005·Antimicrobial Agents and Chemotherapy·C WiuffB R Levin
Jun 6, 2006·The Journal of Antimicrobial Chemotherapy·Ping ChenCarol A Nacy
Jan 12, 2007·Current Opinion in Microbiology·Neeraj Dhar, John D McKinney
Mar 29, 2007·PLoS Medicine·Lynn E ConnollyLalita Ramakrishnan
Apr 1, 2009·Microbiology·Aleksey M AnuchinArseny S Kaprelyants
Apr 25, 2009·Cellular Microbiology·Tige R RustadDavid R Sherman
Oct 31, 2009·American Journal of Respiratory and Critical Care Medicine·Galina V MukamolovaMichael R Barer
Jun 21, 2011·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·A H DiaconP R Donald
Jul 26, 2012·Future Microbiology·Katherine A SackstederCarol A Nacy
Jan 9, 2013·Antimicrobial Agents and Chemotherapy·Brian W KwanThomas K Wood
Sep 28, 2013·The Journal of Antimicrobial Chemotherapy·Jasvir DhillonDenis A Mitchison
Jan 8, 2014·Expert Review of Anti-infective Therapy·Andreas H Diacon, Peter R Donald
Mar 20, 2014·Nature Methods·Martin Krzywinski, Naomi Altman
Sep 10, 2014·The New England Journal of Medicine·Stephen H GillespieUNKNOWN REMoxTB Consortium
Oct 23, 2014·The New England Journal of Medicine·Corinne S MerleUNKNOWN OFLOTUB/Gatifloxacin for Tuberculosis Project
Oct 23, 2014·The New England Journal of Medicine·Amina JindaniUNKNOWN RIFAQUIN Trial Team
Jan 30, 2015·The Journal of Antimicrobial Chemotherapy·Norbert HeinrichUNKNOWN Pan African Consortium for the Evaluation of Antituberculosis Antibiotics PanACEA
Mar 18, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Derek J SloanGeraint R Davies

❮ Previous
Next ❯

Citations

Mar 8, 2016·Expert Opinion on Drug Metabolism & Toxicology·Marlanka A ZuurJan-Willem C Alffenaar
Apr 1, 2016·Expert Review of Respiratory Medicine·Neesha RockwoodRobert J Wilkinson
May 3, 2018·The Journal of Infectious Diseases·Robin J SvenssonUlrika S H Simonsson
Jul 31, 2019·Antimicrobial Agents and Chemotherapy·Robin J SvenssonUlrika S H Simonsson
Jul 7, 2021·Antimicrobial Agents and Chemotherapy·Oluwaseun EgbelowoVéronique Dartois
Oct 5, 2021·Lipids in Health and Disease·Daniel MekonnenAbraham Aseffa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Babesiosis

Babesiosis is caused by parasites of the genus babesia, which are transmitted in nature by the bite of an infected tick. Discover the latest research on babesiosis here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

Journal of Clinical Microbiology
G A Goldfogel, D L Sewell
Journal of the Indian Medical Association
A S Damle, D V Kaundinya
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
F van der Kuyp, C S Mahan
© 2021 Meta ULC. All rights reserved